Overview

Effect of Two Doses of Olmesartan Medoxomil and Amlodipine on Vascular Markers in Hypertensive Patients With Metabolic Syndrome

Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to study the effect of two doses of olmesartan medoxomil and amlodipine on vascular markers in hypertensive patients with metabolic syndrome.
Phase:
Phase 3
Details
Lead Sponsor:
Daiichi Sankyo Europe, GmbH
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Treatments:
Amlodipine
Olmesartan
Olmesartan Medoxomil